Company intelligence / Profile preview

Advanced Infusion Care

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Advanced Infusion Care provides both in-home infusion services and treatment in newly opened outpatient infusion centers, focusing on high patient satisfaction (~99%), accredited nursing care, and individualized therapy for chronic and rare conditions. Clinical outcomes are framed around patient experience and adherence, rather than trial data.

Therapeutic areas: ImmunologyRare Diseases
Modalities: Biologic (immunoglobulin, Alpha-1 antitrypsin therapy)Protein (infusion therapies including immunoglobulin)Small molecule (general FDA-approved drugs administered via infusion)
Industry: Non-Academic Healthcare

Partnerships

URAC and ACHC accreditedmember of Immunoglobulin National Society (IgNS)works with major insurance carriers and healthcare providers

Beyond the preview

Go deeper on Advanced Infusion Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Infusion Care.

Explore the full profile